CLINICAL_TRIALS
trial_result
· 2014-11-05
Clinical Trial Update: Intranasal Oxytocin in the Treatment of Autism [Phase 2]
Summary
A Phase 2 clinical trial evaluating intranasal oxytocin for autism has been completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Evdokia Anagnostou | Conditions: Autism | Phase 2 | Status: COMPLETED | Results posted: 2014-11-05